MediSieve is a London based medical device company, developing and commercialising “magnetic blood filtration”, a new therapeutic platform to revolutionise the treatment of blood-borne diseases. The MediSieve System can selectively remove harmful substances from the bloodstream by continuously circulating a patient’s blood through the system, similarly to dialysis. The technology uses targeted magnetic particles, which bind specifically to the targets in the bloodstream that doctors want to remove. Our R&D is focused on malaria, leukaemia and sepsis.